Top Canadian Viral immunologist Dr. Bryan Concerns of COVID vaccines

Professor at the University of Guelph, and vaccine expert Dr. Bryan Bridle, explains several concerns regarding the rollout of COVID vaccines.

It’s not easy to talk about the COVID vaccine, especially if you are a well known scientist. Any legitimate concerns being raised that paint COVID vaccines in a concerning or “negative” light is likely to be deemed an “anti-vaccine conspiracy theory” by mainstream media, clouding the point that there are a number of legitimate concerns and reasons as to why so many people aren’t taking them.

These are intelligent people, many of the are experts in the field that have been “pro-vaccine” advocates for years, and the fact that they are being labelled as “conspiracy theorists”, ignored, censored, or unacknowledged is quite concerning especially when you consider public transparency.

What Happened: Dr. Bryan Bridle, a viral immunologist and professor at the University of Guelph is one of many who provide good insight as to why COVID vaccine hesitancy may be high among experts like himself. Bridle develops immunization strategies to prevent infectious diseases and treat cancers. He teaches, in his own words, “the value of high-quality, well-validated vaccines and passionately promotes their use. Vaccines are, by far, the most efficient type of medicine; they cost-effectively save millions of people from sickness and/or death.” I personally, and many others would disagree with this statement. But that’s another topic of discussion. I thought it was important to include his stance on vaccines overall.

The information and quotes below come from this interview, this presentation, and this release by the University of Guelph. I suggest you go through them all to get the full picture beyond what’s summarized in this article.

One of the reasons  for hesitancy among academics in the field is natural immunity.

Dr. Bridle explains:

Natural immunity acquired by an ever-growing number of people means fewer people require vaccination to reach herd immunity. As a bonus, natural immunity also equates to broader immunity; these people should be less susceptible to re-infection if an immuno-evasive SARS-CoV-2 variant emerges.

Acquisition of natural immunity, which targets multiple components of the virus, may reduce the risk of re-infection not only with covid-19, but also with variants that can bypass spike protein-specific (vaccine) immunity…It’s just a matter of time before we will have variants that can bypass this narrow immunity conferred by all of these vaccines….Natural immunity is very broad…And we know now there’s lots of published reports that this is protective.

So if a new variant infects, chances are that the immunity you have is going to blunt that infection, where as if you have that narrowly focused immunity conferred by the vaccine, and this variant has evaded that spike protein specific immunity, those people are going to be at much greater risk of more severe disease than those who acquire the new variant, but have this broad acting natural immunity.

And there’s even evidence, interestingly, that those with preexisting immunity against other coronaviruses, including the SARS coronavirus one from 17 years ago, and even from some of the cold causing coronaviruses, can cross protect some people.

So this is the sweet evidence that natural immunity can be pretty good. I actually kind of laugh when I see these publications coming out, because this is kind of immunology 101 that I teach all my students. This is what our immune systems are designed to do.

I’m not aware of any vaccine out there which will ever give you more immunity than if you’re naturally recovered from the illness itself…If you’ve naturally recovered from it, my understanding as a doctor level scientist is that those antibodies will always be better then a vaccine, and if you know any differently, please let me know.

“After having protected themselves while working class were exposed to the virus, the vaccinated Zoomers now want Vaccine Passports where immunity from prior infection does not count, despite stronger evidence for protection. One more assault on working people.”

So those being vaccinated now are, whether they realize it or not, part of the phase three experiment, they part of a vaccination experiment and the companies have openly acknowledged this in their reports to the regulatory agencies, because, for example, there’s a minimum period of time for which they have to track things like the safety of the vaccine.

And indeed they’ve even indicated that. So most people, you know, we’re used to as scientists, usually being able to see published scientifically peer-reviewed data before the vaccines are rolled out. And this won’t happen for probably for about two more years.

And the reason for this is because it’s going to take that long to complete the phase three clinical trials, because a phase three clinical trial, it can not be declared complete until they have monitored the safety of the vaccine for multiple years.

End of interview